DiscoverUehiro Oxford InstituteVaccine policies and challenge trials: the ethics of relative risk in public health
Vaccine policies and challenge trials: the ethics of relative risk in public health

Vaccine policies and challenge trials: the ethics of relative risk in public health

Update: 2021-11-24
Share

Description

In this St Cross Special Ethics Seminar, Dr Sarah Chan outlines some risks arising from the deliberate infection of human participants to infectious agents for research purposes In this St Cross Special Ethics Seminar, Dr Sarah Chan explores three key areas of risk in ‘challenge trials’ – the deliberate infection of human participants to infectious agents as a tool for vaccine development and improving our knowledge of disease biology. Dr Chan explores a) whether some forms of challenge trials cannot be ethically justified; b) why stratifying populations for vaccine allocation by risk profile can result in unjust risk distribution; and c) how comparing these cases and the evaluation of relative risk reveals flaws in approach to pandemic public health.
Comments 
In Channel
Hope in Healthcare

Hope in Healthcare

2022-06-2048:38

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Vaccine policies and challenge trials: the ethics of relative risk in public health

Vaccine policies and challenge trials: the ethics of relative risk in public health

Sarah Chan